RT @Alzhacker: 副作用による462品目の製造販売中止:世界文献のシステマティック・レビュー https://t.co/7YqOrhEoiH 症例報告は、全製品の71%、1950年以降に発売された製品の70%、1960年以降に発売された製品の66%で使用され、回収決…
副作用による462品目の製造販売中止:世界文献のシステマティック・レビュー https://t.co/7YqOrhEoiH 症例報告は、全製品の71%、1950年以降に発売された製品の70%、1960年以降に発売された製品の66%で使用され、回収決定の根拠として最も多く使用された。
RT @MikeWel61647760: @DrNeilStone So who was guilty of medical misinformation on these drugs? Doctors prescribed them for years before the…
@DrNeilStone So who was guilty of medical misinformation on these drugs? Doctors prescribed them for years before the damage was known….https://t.co/YpGGX0H63D
RT @michaelmantzmd: Spontaneous Reports/Case Reports used as the main evidentiary catalyst to alert us to a problem with a drug = 71% Pos…
RT @SarahCo1984: “We identified medicinal products that were withdrawn because of adverse drug reactions, examined the evidence to support…
“We identified medicinal products that were withdrawn because of adverse drug reactions, examined the evidence to support such withdrawals, and explored the pattern of withdrawals across countries.” https://t.co/Q2Demm11LG
@LongCovidNews @Elect76 @UsefulBanter @MissKrisLoves @beverleyturner @martina_ant79 Here you go: https://t.co/WYFuf10LvS The point I made is an excerpt from the Hippocratic Oath which is ‘to do no harm’. There has never been a medicine, vaccine or otherwi
462 drugs said to have met 'strict standards of safety, effectiveness and quality,' have been withdrawn because in real life, they did not meet 'strict standards of safety, effectiveness and quality.' Search terms included fatal, banned and poison. https
RT @michaelmantzmd: Spontaneous Reports/Case Reports used as the main evidentiary catalyst to alert us to a problem with a drug = 71% Pos…
https://t.co/7WDD3D6qbO Many drugs previously approved are subsequently recalled. Might br wise to remember Thalidomide and Losartran. #FDAapproved #FDA
Spontaneous Reports/Case Reports used as the main evidentiary catalyst to alert us to a problem with a drug = 71% PostMarketing Scientific Trials < 20% Full Systematic Review 👇 https://t.co/5zmdJeX8Jj /11
@DrSmartbat @robert_spalding Phen-Fen, and others https://t.co/WUSYD7Lbhg with normal approvals.
@Filiecs2 @MedivalFunTime @BretWeinstein You’re totally wrong, the anecdotal reports are the reason many (most?) drugs are recalled. “The supporting evidence in 72 % of cases consisted of anecdotal reports.” https://t.co/0KcgQwKrKJ
RT @BagueraDaniela: @il_laocoonte @MarcelloLyotard @xnitius hai ragione. peccato che, guardando la storia, farmaci siano stati ritirati dal…
@il_laocoonte @MarcelloLyotard @xnitius hai ragione. peccato che, guardando la storia, farmaci siano stati ritirati dal commercio o fortemente limitati dopo poche segnalazioni (ed è stato aggiunto in leaflet un black box). non ho ancora visto nulla in meri
@Sagar23914504 @Ach_Balkrishna @narendramodi @PMOIndia @drharshvardhan @MoHFW_INDIA @WHO @PTI_News @ani_digital @moayush @IMAIndiaOrg Recent drugs that have been withdrawn from the market: https://t.co/rgKxwOTOBD
@MatthewNewell67 @1967JohnScott @yjdhillhead @IainLees Here's an article for you - it makes for very interesting reading. Look at the average time between introduction & withdrawal, adverse reaction reporting & withdrawal, and the relationship betw
@OdendahlC Zu 1: Weiß ich um ehrlich zu sein nicht. Greift die Einwilligung? Es gibt einen Unterschied zwischen "Nebenwirkung Kopfschmerz" u. "Nebenwirkung Tod". Rücknahmen gibt's immer wieder, hier ist ein Überblick über >450 Stück: https://t.co/l9zggE
@AnkeHassel @jonasdovern @dietmarfehr Nein, also, da gibt's Unterschiede. Wir haben hier die Frage: Wäre der Stoff zugelassen worden, wenn wir mehr Infos gehabt hätten? Vielleicht nein? Es gibt immer wieder Stoffe, die erst zugelassen und dann zurückgenomm
RT @hall_roger: Full report/study here https://t.co/UgzhNeVRpZ
@stefaniaconti @Bruttilde @RobertoBurioni @paridetestani @EricTopol non è vero in 60 as ritirati (ma a vario titolo) meno di 8 farmaci all’anno, dopo una media di 6 anni dall’approvazione. Questi numeri sono fisiologici paragonati all’ENORME progresso dell
@Bruttilde @stefaniaconti @RobertoBurioni @paridetestani @EricTopol infatti non è vero https://t.co/y260mKUecs
RT @Libby30207268: @davidkurten @buckland_jan Anyone remember Thalidomide? Vioxx? https://t.co/AydG7meTCW
@davidkurten @buckland_jan Anyone remember Thalidomide? Vioxx? https://t.co/AydG7meTCW
RT @PVpapers: From weekly guest Eva Montané: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a syste…
RT @PVpapers: From weekly guest Eva Montané: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a syste…
RT @PVpapers: From weekly guest Eva Montané: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a syste…
RT @PVpapers: From weekly guest Eva Montané: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a syste…
From weekly guest Eva Montané: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature https://t.co/ladIV1B7dS
@TonyCowin @MerielMyers Interesting study (if you like that sort of thing - not everyone does) https://t.co/Viu10RrQK4. End
RT @Alvaro_Taype: ¿𝐄𝐧 𝐬𝐞𝐫𝐢𝐨? De 100 fármacos con plausibilidad fisiopatológica que comienzan ensayos clínicos (fase 1), 70 pasan a fase 2,…
¿𝐄𝐧 𝐬𝐞𝐫𝐢𝐨? De 100 fármacos con plausibilidad fisiopatológica que comienzan ensayos clínicos (fase 1), 70 pasan a fase 2, 23 a fase 3, y solo 7 son aprobados para su venta (https://t.co/dDcU6gFasC), de los cuales varios son luego retirados (https://t.co/Sm
La pregunta es, qué hacemos ahora con los protocolos del @Minsa_Peru Cuanto demora la ciencia en llegar a las políticas públicas?
#hydroxychloroquine Muchos fármacos inicialmente parecían prometedores (por fisiopatología y pequeños estudios), pero luego se evidenció que causaban más daños que beneficios. Lo malo es que luego es difícil retirarlos (https://t.co/P5flbESAwb). Recetar
"withdrawal of products following reports of suspected adverse reactions, sufficiently serious to warrant withdrawal, has not improved consistently over the last 60 years" https://t.co/50dOY6PDWg Hmmmmmmm.....
17 Because 462 drugs have been withdrawn from the market since 1953 and this is accelerating https://t.co/1N1LyK9S5t https://t.co/VlPTdUPHPe
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the https://t.co/lm4urK1Q5k
An important article which shows the lack of effective structured internationally coordinated post marketing surveillance of new medicines https://t.co/6LjhMLwOhv
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of ... https://t.co/tmas1PZyU6 #
RT @APRIL_charity: All @BMA_GP @BMAstudents should study how to recognise ADRs https://t.co/GnUcZxyVof as Iatrogenesis is public health cri…
RT @APRIL_charity: All @BMA_GP @BMAstudents should study how to recognise ADRs https://t.co/GnUcZxyVof as Iatrogenesis is public health cri…
All @BMA_GP @BMAstudents should study how to recognise ADRs https://t.co/GnUcZxyVof as Iatrogenesis is public health crisis costing NHS £Mms
Revue de 462 produits pharmaceutiques retirés du marché pour cause d'effets indésirables graves #pharmacovigilance https://t.co/14FV7lZUYe
RT @CRPV_Lille: Retrait du marché de 462 molécules pour des effets indésirables: rôle important de la notification spontanée https://t.co/u…
RT @CRPV_Lille: Retrait du marché de 462 molécules pour des effets indésirables: rôle important de la notification spontanée https://t.co/u…
Retrait du marché de 462 molécules pour des effets indésirables: rôle important de la notification spontanée https://t.co/uapPZYsmEF https://t.co/ck5tje6Vu2
RT @Plouf_007: @HygieSuperBowl A propos d'EI, je viens de tomber sur cet article très intéressant via @montastrucf -> https://t.co/14FV7lZU…
@HygieSuperBowl A propos d'EI, je viens de tomber sur cet article très intéressant via @montastrucf -> https://t.co/14FV7lZUYe
RT @Plouf_007: Étude portant sur 462 médicaments retirés du marché pour cause d'effets (trop) indésirables #patients https://t.co/14FV7lZUYe
Étude portant sur 462 médicaments retirés du marché pour cause d'effets (trop) indésirables #patients https://t.co/14FV7lZUYe
Tres nteressant article sur les effets indesirables des medicaments https://t.co/jrWjgRRv8A
RT @CRPVCentreVdL: guidelines for determining when a drug should be withdrawn when serious ADR are suspected should be developed. https://t…
RT @CRPVCentreVdL: guidelines for determining when a drug should be withdrawn when serious ADR are suspected should be developed. https://t…
RT @CRPVCentreVdL: guidelines for determining when a drug should be withdrawn when serious ADR are suspected should be developed. https://t…
RT @CRPVCentreVdL: guidelines for determining when a drug should be withdrawn when serious ADR are suspected should be developed. https://t…
guidelines for determining when a drug should be withdrawn when serious ADR are suspected should be developed. https://t.co/jnbwIbSZMr
RebeccaChandle1: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systemat… https://t.co/pmfSScs1zK
our review is top 3 cited articles in BMC for 2016-Post-marketing withdrawal of 462 medicinal products https://t.co/HzNcla0NrM
RT @CRPV_Limoges: A propos des #retraits de #Medicaments pour #effetsIndésirables #pharmacovigilance https://t.co/oGJj3KfApF
A propos des #retraits de #Medicaments pour #effetsIndésirables #pharmacovigilance https://t.co/oGJj3KfApF
RT @BrownBagPantry: #Homeopathy is safe.#rxdrugs are not Post-marketing withdrawal 462 medicinal products due 2 adverse drug reactions htt…
#Homeopathy is safe.#rxdrugs are not Post-marketing withdrawal 462 medicinal products due 2 adverse drug reactions https://t.co/48fFtz8onG
RT @UHCW_CEBIS: When and where are drugs withdrawn due to adverse reactions? systematic review: https://t.co/pi9Ljn5peB
When and where are drugs withdrawn due to adverse reactions? systematic review: https://t.co/pi9Ljn5peB
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: systematic review. https://t.co/EM0J…
RT @JuanGrvas: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: systematic review. https://t.co/EM0J…
RT @Aller_MD: “Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review” https://t.co/xxc…
RT @Aller_MD: “Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review” https://t.co/xxc…
RT @Aller_MD: “Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review” https://t.co/xxc…
RT @Aller_MD: “Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review” https://t.co/xxc…
“Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review” https://t.co/xxcmx8bLgi
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: systematic review. https://t.co/EM0J…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
RT @JuanGrvas: Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https:/…
Retirada de medicamentos por efectos adversos. 464 casos. 6 años entre 1ª declaración efecto adverso y su retirada. https://t.co/EM0JbrDaN0
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: systematic review. https://t.co/EM0JbrDaN0
RT @WalterBianchi9: Post-mktg withdrawal of 462 medicinal products because of #adverse_drug_reactions: systematic review https://t.co/poS78…
RT @arriello_group: Insight into 462 #medicines removed due to #ADRs #pv #pharmacovigilance #drugsafety #pharma https://t.co/K3RvejsYf4 htt…
Insight into 462 #medicines removed due to #ADRs #pv #pharmacovigilance #drugsafety #pharma https://t.co/K3RvejsYf4 https://t.co/xSGOo9wAwb
Withdrawal of dangerous #drugs less likely / takes longer in #Africa https://t.co/PYcWxMIqJ1 #globalheath #pharma
Systematic review of literature: Post - marketing withrawal of 462 products due to adverse drug reactions. https://t.co/tD3u43fRe7